Type of security: Fund
The data is delayed by 15 minutes.
Description: The investment seeks to track the investment results of an index composed of large- and mid-capitalization U.S. equities that exhibit growth characteristics. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Russell 1000® Growth Index (the "underlying index"), which measures the performance of large- and mid-capitalization growth sectors of the U.S. equity market. It is a subset of the Russell 1000® Index, which measures the performance of the large-capitalization sector of the U.S. equity market.
|High 52 week||117.57||Low 52 week||94.62||Last close||117.34||Last change||-0.04%|
|RSI||80.35||Average true range||0.54||Beta||0.98||Volume||1.21 M|
|Simple moving average 20 days||1.17%||Simple moving average 50 days||2.58%||Simple moving average 200 days||9.39%|
|Performance Week||0%||Performance Month||3.9%||Performance Quart||6.42%||Performance Half||14.55%|
|Performance Year||20.08%||Performance Year-to-date||12.19%||Volatility daily||0.37%||Volatility weekly||0.83%|
|Volatility monthly||1.71%||Volatility yearly||5.91%||Relative Volume||254.08%||Average Volume||1.53 M|
|New High||New Low|
|30-day SEC yield||Average market capitalization||Average weighted market capitalization||Forward P/E|
|Gross expense ratio||Index dividend yield||Median market cap||Number of holdings||0|
|Price to Book Value||6.33||Price to Earnings||25.21||Total expense ratio||0.2%||Total net assets||22.99 B|
|Weighted market capitalization|
|Total Expense Ratio||0,2|
|Number Of Holdings||n/a|
|Total Net Assets||22 992 833 499,00|
|Google Inc Class A||3,06|
|International Business Machines Corp||2,04|
|Verizon Communications Inc||2|
|Philip Morris International Inc||1,36|
2017-10-13 15:45:07 | 3 Top Ranked Large-Cap Growth ETFs for Your Portfolio
2017-10-02 18:30:44 | The value stock comeback could be a bad sign for the market
2017-09-22 12:14:16 | As Bull Market Ages, Should You Rotate From Growth To Value Stocks?
2017-09-18 07:37:21 | Kevzara May Emerge as a Prominent Rheumatoid Arthritis Drug in 2017
2017-09-15 10:54:12 | Latest Product Launch Expands BD’s Genomics Portfolio
2017-09-05 10:32:30 | Analysts Positive on Edwards Lifesciences: Most Recommend ‘Buy’
2017-09-01 11:06:01 | How Can BSX Improve Its Profitability Going Forward?
2017-09-01 10:38:18 | Intuitive Surgical Plans to Expand in Europe and Asia
2017-08-29 09:07:12 | Becton Dickinson’s CareFusion Synergies and Integration Progress
2017-08-23 09:03:46 | Growth May Keep Trouncing Value
2017-08-17 13:02:00 | The Hindenburg Omen???
2017-08-16 09:07:06 | What Drove Varian to Revise Its Revenue Guidance
2017-08-15 09:05:48 | Varian’s Oncology Business Grows in Emerging Markets
2017-08-03 07:38:33 | Edwards Lifesciences: Focused on Inspiris Resilia and Konect
2017-08-03 07:36:42 | Edwards Lifesciences Focuses on Expanding Market for TAVR Therapy in 2017
2017-07-31 12:05:43 | Why Stryker Updated 2017 Guidance during 2Q17 Earnings Release
2017-07-27 15:14:07 | ETF Winners & Losers on IMF Growth Forecast
2017-07-26 09:08:42 | Wyndham Worldwide: Analysts’ Ratings and Target Prices
2017-07-20 07:42:28 | Stryker: Wall Street Analysts’ Latest Recommendations
2017-07-18 07:37:33 | What’s Driving Intuitive Surgical’s Recent Stock Performance?
2017-07-10 09:09:24 | Inside the Latest BD Collaborations and Growth Accelerators
2017-07-05 07:36:46 | What Are Analysts Recommending for Major US Hotels?
2017-07-04 09:07:50 | What Falling Gas Prices Mean for the Hotel Industry
2017-07-03 09:10:13 | Average Daily Rate Will Drive US Hotel Industry Growth
2017-06-30 10:39:38 | How BSX’s Deep Brain Stimulation Portfolio Is Expanding
2017-06-30 09:45:24 | Market Sell-Off Tough, But Could Offer Opportunities Like These
2017-06-30 08:44:50 | What Analysts Recommend for Boston Scientific
2017-06-29 10:53:17 | 2 Fidelity Blue-Chip Growth Funds: Which Is a Buy?
2017-06-20 14:45:19 | How Did Celgene Perform in 1Q17?
2017-06-15 10:36:09 | Analysts’ Recommendations for AbbVie in June 2017
2017-06-07 09:13:43 | ETFs With Largest Outflows Of The Year
2017-06-05 12:00:00 | These Growth ETFs Are Delivering
2017-06-02 10:36:26 | Understanding Thermo Fisher’s Capital Deployment Strategy
2017-06-02 07:36:43 | Inside Thermo Fisher’s Key Partnerships in Diagnostics
2017-05-31 09:28:09 | Tech rally overdone? The case for buying other stock sectors now
2017-05-17 11:34:03 | 7 Large-Cap Growth ETFs That Are Sizzling
2017-05-17 09:30:01 | The Zacks Analyst Blog Highlights: iShares MSCI ACWI ETF, iShares MSCI India Small-Cap ETF, PowerShares Dynamic Semiconductors Fund, PowerShares QQQ and iShares Russell 1000 Growth ETF
2017-05-16 10:17:02 | 4 High-Flying ETFs & Stocks with More Room to Run
2017-05-15 07:36:32 | Adena Friedman: Corporate Tax Reforms to Improve Economic Activity
2017-05-12 16:28:31 | Social Media, China Internet Stocks Fuel Top ETFs In May
2017-05-09 10:37:07 | Mario Gabelli Believes Infrastructure Spending Will Create Jobs
2017-05-08 10:36:51 | Understanding Boston Scientific’s Key Growth Drivers for MedSurg
2017-05-04 12:59:54 | Millennials ought to be 100% invested in stocks, says top-ranking newsletter editor
2017-05-04 07:37:23 | Can Marriott Improve Its Margin after the Starwood Acquisition?
2017-05-03 14:35:48 | What Marriott’s Key Metrics Suggest ahead of Its 1Q17 Results
2017-05-03 01:00:34 | Millennials ought to be 100% invested in stocks, says top-ranking newsletter editor
2017-05-02 11:06:03 | How Will the S&P 500 Perform in May?
2017-05-02 10:37:52 | Looking at Hyatt’s Valuation ahead of Its 1Q17 Earnings
2017-05-02 09:09:32 | Will Hyatt Start Paying Dividends in 2017?
2017-05-02 07:39:14 | Hyatt Looks to Continue Its Revenue Growth in 2017